[Albumin metabolism in congestive circulatory insufficiency].
The examination was conducted in 78 patients with congestive circulatory insufficiency. Albumin metabolism was studied in these patients with the aid of 1(131)--labelled albumin after Metthews. The half-life of albumin was studied, as well as the decay speed factor and the synthesis rate. The plasma albumin level was determined. Changes in the half-life duration were revealed. Patients with Stage III dystrophic circulatory insufficiency were shown to have a reduced plasma albumin level, a shortened albumin half-life, and increased synthesis rate and decay factors. Patients with Stage II-A and B circulatory insufficiency had varying changes of these parameters differing from the normal range.
D000328:Adult; D000368:Aged; D000418:Albumins / Q000096:biosynthesis / Q000378:metabolism*; D003327:Coronary Disease / Q000150:complications; D005260:Female; D006207:Half-Life; D006333:Heart Failure / Q000209:etiology / Q000378:metabolism*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012214:Rheumatic Heart Disease / Q000150:complications; D012709:Serum Albumin / Q000032:analysis; D012711:Serum Albumin, Radio-Iodinated
D000418:Albumins; D012709:Serum Albumin; D012711:Serum Albumin, Radio-Iodinated
Obmen al'bumina pri zastoĭnoĭ nedostatochnosti krovoobrashcheniia